Michelle Shaw

510 total citations
40 papers, 315 citations indexed

About

Michelle Shaw is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Michelle Shaw has authored 40 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Physiology. Recurrent topics in Michelle Shaw's work include Cystic Fibrosis Research Advances (25 papers), Neonatal Respiratory Health Research (12 papers) and Tracheal and airway disorders (7 papers). Michelle Shaw is often cited by papers focused on Cystic Fibrosis Research Advances (25 papers), Neonatal Respiratory Health Research (12 papers) and Tracheal and airway disorders (7 papers). Michelle Shaw collaborates with scholars based in Canada, United States and Australia. Michelle Shaw's co-authors include Félix Ratjen, Valerie Waters, Melinda Solomon, Stephanie D. Davis, Sanja Stanojevic, Hartmut Grasemann, Lucy Perrem, Brian L. Strom, Steven M. Rowe and Scott H. Donaldson and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and The Journal of Pediatrics.

In The Last Decade

Michelle Shaw

36 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle Shaw Canada 9 163 79 38 34 28 40 315
Harriet Shannon United Kingdom 12 203 1.2× 21 0.3× 53 1.4× 9 0.3× 26 0.9× 36 308
Indranil Chakravorty United Kingdom 10 142 0.9× 29 0.4× 44 1.2× 15 0.4× 99 3.5× 42 314
Keiko Yamasaki Japan 9 29 0.2× 28 0.4× 48 1.3× 37 1.1× 26 0.9× 21 343
Robert Steppacher United States 9 232 1.4× 65 0.8× 88 2.3× 41 1.2× 6 0.2× 18 471
Carl R Hinkson United States 8 60 0.4× 56 0.7× 74 1.9× 16 0.5× 12 0.4× 14 237
Jun Kako Japan 10 87 0.5× 41 0.5× 26 0.7× 13 0.4× 63 2.3× 52 299
Andrew Bugajski United States 9 42 0.3× 31 0.4× 56 1.5× 14 0.4× 8 0.3× 28 235
Asha Shenoi United States 7 40 0.2× 23 0.3× 78 2.1× 17 0.5× 16 0.6× 20 234
Wan Yen Lim Singapore 10 60 0.4× 53 0.7× 130 3.4× 23 0.7× 15 0.5× 31 285
M McDonnell Ireland 11 151 0.9× 37 0.5× 48 1.3× 8 0.2× 14 0.5× 20 381

Countries citing papers authored by Michelle Shaw

Since Specialization
Citations

This map shows the geographic impact of Michelle Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Shaw more than expected).

Fields of papers citing papers by Michelle Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Shaw. The network helps show where Michelle Shaw may publish in the future.

Co-authorship network of co-authors of Michelle Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Shaw. A scholar is included among the top collaborators of Michelle Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Shaw. Michelle Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Waters, Valerie, Michelle Shaw, Lucy Perrem, et al.. (2024). A randomised trial of oral prednisone for cystic fibrosis pulmonary exacerbation treatment. European Respiratory Journal. 63(6). 2302278–2302278. 5 indexed citations
3.
Shaw, Michelle, et al.. (2024). Lung Function Recovery from Pulmonary Exacerbations Treated with Oral Antibiotics in Primary Ciliary Dyskinesia. Annals of the American Thoracic Society. 22(5). 724–731.
4.
Perrem, Lucy, et al.. (2024). SPLUNC1 as a biomarker of pulmonary exacerbations in children with cystic fibrosis. Journal of Cystic Fibrosis. 23(2). 288–292. 1 indexed citations
5.
Blanchard, Ana C., Michelle Shaw, Félix Ratjen, et al.. (2023). Factors associated with lung function response with oral antibiotic treatment of pulmonary exacerbations in cystic fibrosis. Journal of Cystic Fibrosis. 22(5). 880–883. 4 indexed citations
6.
Pollak, Mordechai, et al.. (2023). Longitudinal Assessment of Curaçao Criteria in Children with Hereditary Hemorrhagic Telangiectasia. The Journal of Pediatrics. 263. 113665–113665. 10 indexed citations
7.
Waters, Valerie, et al.. (2023). Treatment Response to Pulmonary Exacerbation in Primary Ciliary Dyskinesia. A6105–A6105.
8.
Shaw, Michelle, et al.. (2023). Efficacy of Antibiotic Eradication Therapy of Early Pseudomonas aeruginosa Infection in Children with Primary Ciliary Dyskinesia. Annals of the American Thoracic Society. 20(6). 854–860. 7 indexed citations
9.
Shaw, Michelle, et al.. (2022). Impact of antibiotic eradication therapy of Pseudomonas aeruginosa on long term lung function in cystic fibrosis. Journal of Cystic Fibrosis. 22(1). 98–102. 9 indexed citations
10.
Kopp, Matthias, et al.. (2022). Interleukin-1 beta is a potential mediator of airway nitric oxide deficiency in cystic fibrosis. Journal of Cystic Fibrosis. 21(4). 623–625. 2 indexed citations
11.
Pollak, Mordechai, Michelle Shaw, David C. Wilson, et al.. (2021). Bronchodilator responsiveness in cystic fibrosis children treated for pulmonary exacerbations. Pediatric Pulmonology. 56(7). 2036–2042. 2 indexed citations
12.
Stanojevic, Sanja, Stephanie D. Davis, Lucy Perrem, et al.. (2021). Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis. European Respiratory Journal. 58(1). 2003380–2003380. 20 indexed citations
13.
Pollak, Mordechai, Michelle Shaw, David C. Wilson, Hartmut Grasemann, & Félix Ratjen. (2020). Bronchodilator responsiveness in children with cystic fibrosis and allergic bronchopulmonary aspergillosis. European Respiratory Journal. 56(2). 2000175–2000175. 2 indexed citations
14.
Pollak, Mordechai, Michelle Shaw, Susan Balkovec, et al.. (2020). Infant spirometry as a predictor of lung function at early childhood in cystic fibrosis patients. Journal of Cystic Fibrosis. 20(6). 937–940. 1 indexed citations
15.
Perrem, Lucy, Sanja Stanojevic, Michelle Shaw, et al.. (2020). Lung Clearance Index to Track Acute Respiratory Events in School-Age Children with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 203(8). 977–986. 34 indexed citations
16.
Shaw, Michelle, Umer Khan, John Clancy, et al.. (2020). Changes in LCI in F508del/F508del patients treated with lumacaftor/ivacaftor: Results from the prospect study. Journal of Cystic Fibrosis. 19(6). 931–933. 28 indexed citations
17.
Shaw, Michelle, et al.. (2015). Suicide Assessment and Nurses: What Does the Evidence Show?. OJIN The Online Journal of Issues in Nursing. 20(1). 2–2. 87 indexed citations
18.
Shaw, Michelle. (2002). When is perioperative 'steroid coverage' necessary?. Cleveland Clinic Journal of Medicine. 69(1). 9–11. 7 indexed citations
19.
Yarbrough, Tom B., et al.. (1999). Persistent Frenulum of the Epiglottis in Four Foals. Veterinary Surgery. 28(4). 287–291. 7 indexed citations
20.
Grisso, Jeane Ann, et al.. (1997). Epidemiological pitfalls using medicaid data in reproductive health research. The Journal of Maternal-Fetal Medicine. 6(4). 230–236. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harriet Shannon Breakdown of academic impact, for papers by Indranil Chakravorty Breakdown of academic impact, for papers by Keiko Yamasaki Breakdown of academic impact, for papers by Robert Steppacher Breakdown of academic impact, for papers by Carl R Hinkson Breakdown of academic impact, for papers by Jun Kako Breakdown of academic impact, for papers by Andrew Bugajski Breakdown of academic impact, for papers by Asha Shenoi Breakdown of academic impact, for papers by Wan Yen Lim Breakdown of academic impact, for papers by M McDonnell
Rankless by CCL
2026